Metoprolol: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
Line 6: Line 6:


==[[Metoprolol overview|Overview]]==
==[[Metoprolol overview|Overview]]==
==[[Metoprolol class|Class]]==
==[[General Information]]==
==[[Lopressor FDA Package Insert]]==
==[[Lopressor FDA Package Insert]]==


==[[Toprol FDA Package Insert]]==
==[[Toprol FDA Package Insert]]==
==[[Clinical Trials]]==
==[[Clinical Trials]]==

Revision as of 16:27, 12 March 2014

Metoprolol
Clinical data
Trade namesLopressor, Toprol-xl
AHFS/Drugs.comMonograph
MedlinePlusa682864
[[Regulation of therapeutic goods |Template:Engvar data]]
Pregnancy
category
  • AU: C
  • US: C (Risk not ruled out)
Routes of
administration
Oral, IV
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability12%
MetabolismHepatic via CYP2D6, CYP3A4
Elimination half-life3-7 hours
ExcretionRenal
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC15H25NO3
Molar mass267.364 g/mol
3D model (JSmol)
Melting point120 °C (248 °F)
  (verify)

For patient information about Metoprolol, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

General Information

Lopressor FDA Package Insert

Toprol FDA Package Insert

Clinical Trials